Nursing home residents with pre-existing cognitive or functional impairments were at a higher risk of functional decline after taking beta-blockers following acute myocardial infarction, study shows.
The US Food and Drug Administration has approved the first corticosteroid to be made available in the United States for the treatment of patients with Duchenne muscular dystrophy.
UK health minister David Mowat says that the Murray review into the provision of community pharmacy services will “direct” government policy.
The Pharmacists’ Defence Association Union (PDAU) has lost the latest round of its on-going battle with Boots to win the right to represent the company’s pharmacists on pay, hours and holidays.
The UK government has confirmed that Brexit will not put a stop to its plans to implement the EU’s Falsified Medicines Directive, Martin Sawer, executive director of the Healthcare Distribution Association, told delegates at the Sigma conference in Rio de Janeiro on 14 February 2017.